September 5, 2013 2:28 PM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Shares of Rockwell Medical (NASDAQ: RMTI) have rallied more than 36 percent Thursday afternoon following a boosted price target from one of the few analysts who currently cover the stock. Traders and analysts are responding to news from Wednesday morning the company's SFP met both primary and secondary endpoints in a Phase 3 CRUISE-2 study. Shares of Rockwell rallied about 8 percent over the course of Wednesday's trading session.Summer Street's Carol Werther lifted her price target on shares of Rockwell earlier from $20 to $25 while maintaining a Buy rating. With Rockwell Medical shares last trading around $8.10, the Summer Street analyst's new price target represents potential upside of a whopping 200-plus percent from where the stock is currently trading.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.